Inventor · disambiguated record
James Allison
Also filed as: ALLISON JAMES · ALLISON JAMES P · ALLISON JAMES PATRICK
14 granted patents·17 pending applications·1,703 citations·filing 1995–2021
94Inventor score
Files withUNIV TEXAS12UNIV CALIFORNIA7ALLISON JAMES2ICAHN SCHOOL MED MOUNT SINAI2ALBERT EINSTEIN COLLEGE MEDICINE1
Top patents by PatentIndex Score
31 records- 0197US6051227ABlockade of T lymphocyte down-regulation associated with CTLA-4 signalingUNIV CALIFORNIA·Filed 1996·Granted Apr 18, 2000·490 cites·23 claims
- 0297US5811097ABlockade of T lymphocyte down-regulation associated with CTLA-4 signalingUNIV CALIFORNIA·Filed 1996·Granted Sep 22, 1998·716 cites·11 claims
- 0396US5855887ABlockade of lymphocyte down-regulation associated with CTLA-4 signalingUNIV CALIFORNIA·Filed 1995·Granted Jan 5, 1999·345 cites·12 claims
- 0493US8709417B2Combination immunotherapy for the treatment of cancerALLISON JAMES·Filed 2010·Granted Apr 29, 2014·44 cites·6 claims
- 0593US7919079B2Cancer immunotherapy compositions and methods of useBIOSANTE PHARMACEUTICALS INC·Filed 2007·Granted Apr 5, 2011·16 cites·28 claims
- 0692US9375475B2Combination immunotherapy for the treatment of cancerUNIV TEXAS·Filed 2014·Granted Jun 28, 2016·18 cites·10 claims
- 0787US10167337B2Combination immunotherapy for the treatment of cancerUNIV TEXAS·Filed 2018·Granted Jan 1, 2019·4 cites·19 claims
- 0887US10023637B2Combination immunotherapy for the treatment of cancerUNIV TEXAS·Filed 2016·Granted Jul 17, 2018·5 cites·19 claims
- 0987US9447186B2Antibodies to human B7x for treatment of metastatic cancerZANG XINGXING·Filed 2013·Granted Sep 20, 2016·10 cites·15 claims
- 1084US9868961B2Methods and compositions for localized secretion of anti-CTLA-4 antibodiesALLISON JAMES·Filed 2007·Granted Jan 16, 2018·12 cites·14 claims
- 1181US7229628B1Blockade of T lymphocyte down-regulation associated with CTLA-4 signalingUNIV CALIFORNIA·Filed 1999·Granted Jun 12, 2007·43 cites·10 claims
- 1275US2022162315A1Combination Immunotherapy For The Treatment of CancerUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1371US12221489B2Antibodies to human B7x for treatment of metastatic cancerALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Feb 11, 2025·0 cites·13 claims
- 1468US2009269353A1Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking AgentsUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 1564US2019352398A1Combination Immunotherapy For The Treatment of CancerUNIV TEXAS·Filed 2018·Application pending·0 cites
- 1660US2014271677A1Newcastle Disease Viruses and Uses ThereofSLOAN KETTERING INST CANCER·Filed 2014·Application pending·0 cites
- 1760US2016015760A1Newcastle disease viruses and uses thereofICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Application pending·0 cites
- 1858US2017029525A1Antibodies to human b7x for treatment of metastatic cancerALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Application pending·0 cites
- 1957US2018078592A1Newcastle Disease Viruses And Uses ThereofICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Application pending·0 cites
- 2056US2022053740A1A genetic mouse model of autoimmune adverse events and immune checkpoint blockade therapyUNIV TEXAS·Filed 2019·Application pending·0 cites
- 2154US2023184771A1Methods for treating bladder cancerUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2253US12180277B2LILRB4-binding antibody and methods of use thereofUNIV TEXAS·Filed 2020·Granted Dec 31, 2024·0 cites·20 claims
- 2353US2023255978A1Methods for treating glioblastomaUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2452US2023348599A1Methods for treating glioblastomaUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2552US2005249700A1Blockade of T lymphocyte down-regulation associated with CTLA-4 signalingALLISON JAMES P·Filed 2004·Application pending·0 cites
- 2652US2013309267A1Cancer immunotherapy compositions and methods of useSIMMONS ANDREW·Filed 2011·Application pending·0 cites
- 2751US2021260051A1Combination of ezh2 inhibitor and checkpoint therapy for the treatment of cancerUNIV TEXAS·Filed 2019·Application pending·0 cites
- 2847US2020123258A1Targeting b cells to enhance response to immune checkpoint blockadeUNIV TEXAS·Filed 2019·Application pending·0 cites
- 2942US7704701B2Diagnosis of prostate cancer with SPAS-1 cancer antigenUNIV CALIFORNIA·Filed 2007·Granted Apr 27, 2010·0 cites·3 claims
- 3042US2006034844A1Stimulation of T cells against self antigens using CTLA-4 blocking agentsUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3138US2002150588A1SPAS-1 cancer antigenFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Allison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →